SCIENTIFIC HUB

Follow the evidence.

191.034 articles found

Open access

Neuronal α-Synuclein Disease Stage Progression over 5 Years.

Simuni T, Gochanour C, Nair AR, Brumm MC, Coffey C, Poston KL, Chahine LM, Weintraub D, Tanner CM, Gonzalez-Latapi P, Kopil CM, Xiao Y, Chowdhury S, Dam T, Pagano G, Stephenson D, Siderowf A, Dunn B, Marek K, NSD Working Group the Parkinson's Progression Markers Initiative.

Mov Disord · 2025-04-30

DOI: 10.1002/mds.30191PMID: 40302527

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Healthcare resource utilization patterns among patients with Parkinson's disease psychosis and dementia: analysis of US Medicare beneficiaries treated with pimavanserin versus other-atypical antipsychotics or versus quetiapine.

Rajagopalan K, Gopal D, Chrones L, Doshi D, Rashid N.

J Med Econ · 2025-04-30

DOI: 10.1080/13696998.2025.2487358PMID: 40167335

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases.

Lissoni P, Rovelli F, Monzon A, Messina G, Merli N, Tartarelli R, Tassoni S, Zecchinato F, Simoes-E-Silva AC, Valentini A, Di Fede G, Cardinali DP.

Clin Interv Aging · 2025-04-29

DOI: 10.2147/cia.s513910PMID: 40330271

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.